Skip to content
TrialScanner

NCT04614558

Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance

Phase 2CompletedSNYCollaborator

Registry record

Lead sponsor
Columbia University
Conditions
Monoclonal Gammopathy
Primary completion
Oct 23, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04614558 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

3 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04614558: Isatuximab in Patients With... | TrialScanner